Pegylated-P-Interferon-alpha-2b (P1101)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated-P-Interferon-alpha-2b (P1101), covering 2021-10-15 to 2021-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection [Phase 2]